Trial Profile
A Phase I/II Randomized, Controlled Study of OGT 918 in Adult and Juvenile Patients With Niemann Pick C Disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Miglustat (Primary)
- Indications Niemann-Pick disease type C
- Focus Therapeutic Use
- 02 Feb 2017 New trial record